source
- Kardigan secures $400 million IPO to fund three clinical-stage cardiovascular candidatesKardigan, a New Jersey biotech focused on heart disease, announced it raised $400 million in a Nasdaq initial public offering. The capital will be directed toward advancing three clinical-stage dr…
- Biogen to acquire San Diego biotech RayThera in up to $1 billion dealBiogen announced it will acquire RayThera, a San Diego-based biotech, in a transaction valued at up to $1 billion. The agreement specifies that most of the payment will be made through milestone-b…